Brief Attacks of Narcolepsy in the Elderly: detect and manage your dad

Important Clarification

---

1. True Narcolepsy in the Elderly (Rare)

Epidemiology

• Peak onset: ages 15-25 years
• New-onset narcolepsy after age 60 is extremely rare (< 5% of cases)
• Most elderly patients with narcolepsy were diagnosed in their youth/middle age

Characteristics in Elderly

• Same core symptoms as younger patients:
  • Excessive daytime sleepiness (EDS)
  • Cataplexy (sudden muscle weakness with emotions) – Type 1
  • Sleep paralysis
  • Hypnagogic/hypnopompic hallucinations
  • Disrupted nighttime sleep

Why It’s Rare in the Elderly

• Hypocretin/orexin cell loss occurs earlier in life
• Secondary causes become more likely with age
• Diagnostic criteria harder to meet in the elderly

---

2. “Narcolepsy-Like” Symptoms in the Elderly (Common)

Differential Diagnosis – What It Usually IS:

A. Sleep Apnea (Most Common)

Obstructive Sleep Apnea (OSA):

• Affects 30-80% of the elderly
• Causes severe daytime sleepiness
• Brief “sleep attacks” during the day
• Snoring, witnessed apneas
• Morning headaches
• Diagnosis: Polysomnography (sleep study)
• Treatment: CPAP, weight loss, positional therapy

B. Medication Side Effects (Very Common)

Sedating Medications:

• Benzodiazepines (lorazepam, diazepam)
• Sedating antidepressants (mirtazapine, trazodone)
• Antihistamines (diphenhydramine, hydroxyzine)
• Opioid pain medications
• Anticonvulsants (gabapentin, pregabalin)
• Antipsychotics (quetiapine, olanzapine)
• Muscle relaxants
• Anti-Parkinson medications

Polypharmacy:

• Elderly often on multiple sedating drugs
• The cumulative effect causes excessive sleepiness
• Review the medication list first!

---

2. “Narcolepsy-Like” Symptoms in the Elderly (Continued)

C. Neurodegenerative Disorders

Parkinson’s Disease:

• Excessive daytime sleepiness very common (50-75%)
• Sudden “sleep attacks” can occur
• May fall asleep during activities (even driving)
• Related to disease itself AND medications (dopamine agonists)
• Other Parkinson’s symptoms present (tremor, rigidity, bradykinesia)

Dementia (All Types):

• Alzheimer’s disease
• Lewy body dementia (especially)
• Frontotemporal dementia
• Disrupted sleep-wake cycle
• Daytime somnolence common
• “Sundowning” – worse in the afternoon/evening

Multiple System Atrophy:

• REM sleep behavior disorder
• Excessive daytime sleepiness
• Autonomic dysfunction

D. Secondary Narcolepsy (Symptomatic)

Brain Lesions:

• Stroke (especially hypothalamus, brainstem)
• Brain tumors affecting the hypothalamus
• Traumatic brain injury
• Multiple sclerosis
• Paraneoplastic syndromes

Characteristics:

• Acquired after brain injury/lesion
• MRI shows a structural abnormality
• May have other neurological symptoms
• Hypocretin levels may be normal or low

---

2. “Narcolepsy-Like” Symptoms in the Elderly (Continued)

E. Other Medical Conditions

Metabolic/Endocrine:

• Hypothyroidism (very common in the elderly)
• Diabetes with poor control
• Chronic kidney disease
• Chronic liver disease
• Anemia
• Electrolyte imbalances

Cardiac:

• Congestive heart failure
• Arrhythmias causing poor perfusion

Psychiatric:

• Depression (hypersomnia subtype)
• Bipolar disorder (depressive phase)

Nutritional:

• Vitamin B12 deficiency
• Vitamin D deficiency

F. Insufficient Sleep Syndrome

• Simply not getting enough sleep at night
• The most common cause of daytime sleepiness!
• Poor sleep hygiene
• Insomnia
• Nocturia (frequent urination at night)
• Pain interfering with sleep

---

Clinical Evaluation

History Taking

Key Questions:

1. When did symptoms start?
   • Lifelong vs. recent onset (suggests secondary cause)
2. Description of “sleep attacks”:
   • Sudden, irresistible urge to sleep?
   • Can they be resisted or delayed?
   • Duration (seconds vs. minutes vs. hours)?
   • Refreshing or non-refreshing?
3. Cataplexy present? (Most specific for narcolepsy)
   • Sudden muscle weakness triggered by emotions (laughing, surprise)
   • Consciousness maintained
   • Brief (seconds to 2 minutes)
   • If NO cataplexy, probably NOT narcolepsy Type 1
4. Nighttime sleep quality:
   • Snoring? Witnessed apneas? (suggests sleep apnea)
   • Restless sleep? Acting out dreams? (REM behavior disorder)
   • Frequent awakenings?
   • Total sleep time?
5. Other symptoms:
   • Sleep paralysis?
   • Hallucinations when falling asleep/waking?
   • Cognitive changes?
   • Motor symptoms (Parkinson’s)?
6. Medication review:
   • Complete list with doses and timing
   • Recent additions or changes?
7. Medical history:
   • Neurological disorders?
   • Psychiatric disorders?
   • Recent stroke or head injury?

---

Diagnostic Workup

Initial Evaluation

Physical Examination:

• Neurological exam (looking for Parkinson’s, stroke, other signs)
• Cognitive assessment (dementia screening)
• Neck circumference, BMI (sleep apnea risk)
• Blood pressure (orthostatic hypotension)

Laboratory Tests:

• Complete blood count (anemia)
• Comprehensive metabolic panel
• Thyroid function (TSH, free T4)
• Vitamin B12, folate
• Hemoglobin A1c (diabetes)
• Liver and kidney function

Imaging:

• Brain MRI if:
  • Sudden onset
  • Focal neurological signs
  • Other neurological symptoms
  • Atypical presentation

---

Diagnostic Workup (Continued)

Sleep Studies

Polysomnography (PSG) – Overnight Sleep Study:

• Rule out sleep apnea (the most common treatable cause)
• Assess sleep architecture
• REM sleep behavior disorder
• Periodic limb movements

Multiple Sleep Latency Test (MSLT):

• Done the day after PSG
• Measures how quickly a patient falls asleep during the day
• Look for REM sleep onset during naps
• Narcolepsy criteria:
  • Mean sleep latency ≤ 8 minutes
  • ≥ 2 sleep-onset REM periods (SOREMPs)
• Limitations in the elderly:
  • Sleep apnea can cause a false positive
  • Medications affect results
  • Less validated in older adults

CSF Hypocretin-1 Measurement:

• Requires a lumbar puncture
• Low levels (< 110 pg/mL) are diagnostic for narcolepsy Type 1
• Rarely done in the elderly
• May be normal in secondary narcolepsy

---

Management Approach

1. Treat Underlying Cause First

If Sleep Apnea:

• CPAP therapy (first-line)
• Often resolves daytime sleepiness completely
• Dental appliances
• Positional therapy
• Weight loss if applicable

If Medication-Related:

• Review and minimize sedating medications
• Adjust timing (sedating meds at bedtime)
• Consider alternatives
• Taper/discontinue if possible

If Medical Condition:

• Treat hypothyroidism (levothyroxine)
• Optimize diabetes control
• Treat anemia
• Manage heart failure
• Address depression

If Parkinson’s Disease:

• Optimize Parkinson’s medications
• May need stimulants for EDS
• Consider modafinil/armodafinil
• Address medication-related sleepiness (reduce dopamine agonist)

---

Management Approach (Continued)

2. Non-Pharmacological Management

Sleep Hygiene:

• Regular sleep schedule (same bedtime/wake time)
• Adequate sleep duration (7-8 hours)
• Dark, quiet, cool bedroom
• Limit daytime napping (or scheduled strategic naps)
• Morning light exposure
• Avoid caffeine after noon
• Avoid alcohol (disrupts sleep)

Behavioral Strategies:

• Scheduled naps (15-20 minutes, early afternoon)
• Avoid activities when sleepy (especially driving)
• Engage in stimulating activities
• Social interaction
• Physical activity (morning is best)

Safety Measures:

• No driving if uncontrolled sleepiness
• Avoid dangerous activities when sleepy
• Fall prevention (if sudden sleep attacks)

---

Management Approach (Continued)

3. Pharmacological Treatment

If True Narcolepsy or Refractory EDS:

First-Line: Wake-Promoting Agents

Modafinil (Provigil):

• Dose: Start 100 mg daily in the morning, increase to 200-400 mg
• Preferred in the elderly (fewer side effects)
• Better tolerated than traditional stimulants
• Side effects: headache, nausea, anxiety
• Drug interactions: CYP3A4 inducer

Armodafinil (Nuvigil):

• R-enantiomer of modafinil
• Dose: 150-250 mg once daily in the morning
• Longer half-life than modafinil
• Similar efficacy and side effects

Cautions in the Elderly:

• Start low, go slow
• Monitor blood pressure (can increase)
• Monitor for psychiatric effects (anxiety, agitation)
• Assess cardiac status before starting

---

Management Approach (Continued)

3. Pharmacological Treatment (Continued)

Second-Line: Traditional Stimulants

Methylphenidate (Ritalin, Concerta):

• Dose: Start 5-10 mg daily, can divide doses
• Maximum usually 60 mg/day
• More side effects than modafinil
• Use with caution in the elderly

Side Effects/Risks:

• Increased blood pressure, heart rate
• Anxiety, agitation, insomnia
• Appetite suppression (concern in frail elderly)
• Abuse potential
• Cardiac arrhythmias

Contraindications:

• Severe hypertension
• Recent myocardial infarction
• Significant cardiac arrhythmias
• Hyperthyroidism
• Glaucoma
• Agitated states

Generally AVOID in the elderly unless no alternatives

---

Management Approach (Continued)

3. Pharmacological Treatment (Continued)

For Cataplexy (if present):

Sodium Oxybate (Xyrem/Xywav):

• Not typically used in the elderly
• High sodium content (Xyrem)
• Risk of confusion, respiratory depression
• Difficult administration (twice nightly)

Antidepressants (off-label for cataplexy):

• Venlafaxine (SNRI): 75-150 mg daily
• Fluoxetine (SSRI): 20-40 mg daily
• Generally better tolerated in the elderly
• Less evidence than younger patients

---

Special Considerations in the Elderly

1. Diagnostic Challenges

• Multiple comorbidities complicate diagnosis
• Polypharmacy obscures the clinical picture
• Cognitive impairment affects history
• Sleep studies more difficult (compliance)
• Normal aging includes some increased daytime sleepiness

2. Treatment Challenges

• More sensitive to medication side effects
• Drug-drug interactions
• Cardiovascular considerations
• Falls risk
• Cognitive side effects
• Reduced renal/hepatic clearance

3. Functional Impact

• Increased fall risk with sudden sleep attacks
• Driving safety major concern
• Social isolation
• Depression risk
• Caregiver burden

---

Red Flags – When to Refer

Refer to the Sleep Specialist if:

• Diagnostic uncertainty
• Cataplexy present (suggests true narcolepsy)
• Failed initial management
• Complex sleep disorders
• Need for MSLT interpretation
• Severe, refractory symptoms

Refer to Neurology if:

• Sudden onset with neurological signs
• Suspected Parkinson’s disease
• Other movement disorders
• Cognitive decline
• Suspected secondary narcolepsy

Refer to Psychiatry if:

• Significant depression or anxiety
• Medication management complex
• Behavioral issues

---

Clinical Pearls

Key Points to Remember:

1. New-onset narcolepsy after age 60 is RARE – always look for other causes first
2. Sleep apnea is the most common cause of narcolepsy-like symptoms in elderly
3. Review medications thoroughly – often the culprit
4. Parkinson’s disease commonly causes excessive daytime sleepiness and sleep attacks
5. Cataplexy is key – if absent, probably not narcolepsy Type 1
6. Secondary causes are more likely in the elderly (stroke, tumors, neurodegeneration)
7. Treat the underlying cause first before using stimulants
8. Start low, go slow with any medications in the elderly
9. Safety is paramount – assess driving, fall risk
10. A multidisciplinary approach is often needed (neurology, sleep medicine, geriatrics)

---

Case Example

Case: 72-year-old man, “falls asleep suddenly” during the day

History:

• 6-month history of daytime sleepiness
• Falls asleep watching TV, during conversations
• Wife reports loud snoring, gasping at night
• Recently started on gabapentin for neuropathy
• Gained 15 pounds in past year
• No cataplexy, no sleep paralysis
• No cognitive decline

Diagnosis:

1. Obstructive sleep apnea (primary cause)
2. Medication effect (gabapentin)
3. Weight gain (contributing factor)

Management:

• Sleep study confirmed severe OSA (AHI 45)
• Started CPAP therapy
• Reduced gabapentin dose, taken at bedtime only
• Weight loss counseling
• Result: Complete resolution of daytime sleepiness

NOT narcolepsy!

---

Summary

Bottom Line:

“Brief attacks of narcolepsy” in the elderly are usually:

1. Sleep apnea (most common)
2. Medications (very common)
3. Parkinson’s disease (common in this age)
4. Other medical conditions (thyroid, anemia, etc.)
5. True narcolepsy (rare)

Approach:

• Comprehensive evaluation for secondary causes
• Sleep study to rule out sleep apnea
• Medication review and optimization
• Treat underlying conditions
• Non-pharmacological interventions first
• Medications cautiously if needed
• Multidisciplinary care